MRTX logo

Mirati Therapeutics (MRTX) Net Income

Annual Net Income

-$740.87 M
-$159.08 M-27.34%

December 31, 2022

Summary

Performance

1-Year Change

-27.34%

3-Year Change

-248.08%

5-Year Change

-951.11%

15-Year Change

-951.11%

MRTX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.22 M

3-Year Low

-$740.87 M
MRTX annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
MRTX previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
MRTX next annual earnings announcement has not yet been scheduled

OtherMRTXprofitabilitymetrics:

Annual Net Margin

-5957.44%
MRTX annual net profit margin is -5957.44%

Annual Revenue

$12.44 M
MRTX annual revenue is $12.44 million

Annual Gross Profit

$11.84 M
MRTX annual gross profit is $11.84 million

Annual EPS

-$13.18
MRTX annual earnings per share is -$13.18

Quarterly Net Income

-$161.90 M
+$15.01 M+8.48%

September 30, 2023

Summary

Performance

3-Month Change

+8.48%

1-Year Change

+6.72%

3-Year Change

-83.64%

5-Year Change

-489.41%

MRTX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.73 M
MRTX quarterly net profit is currently -2194.00% below its historical high of $7.73 million

3-Year Low

-$202.47 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
MRTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
MRTX next earnings announcement has not yet been scheduled

OtherMRTXprofitabilitymetrics:

Quarterly Net Margin

-987.22%
MRTX quarterly net profit margin is -987.22%

Quarterly Revenue

$16.40 M
MRTX quarterly revenue is $16.40 million

Quarterly Gross Profit

$14.71 M
MRTX quarterly gross profit is $14.71 million

Quarterly EPS

-$2.49
MRTX quarterly earnings per share is -$2.49

TTM Net Income

-$725.88 M
+$11.66 M+1.58%

September 30, 2023

Summary

Performance

3-Month Change

+1.58%

1-Year Change

+1.64%

3-Year Change

-120.98%

5-Year Change

-241.03%

MRTX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.33 M

3-Year Low

-$740.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
MRTX previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
MRTX next earnings announcement has not yet been scheduled

OtherMRTXprofitabilitymetrics:

Annual Net Margin

-5957.44%
MRTX annual net profit margin is -5957.44%

TTM Revenue

$38.19 M
MRTX TTM revenue is $38.19 million

TTM Gross Profit

$33.80 M
MRTX TTM gross profit is $33.80 million

TTM EPS

-$12.22
MRTX TTM earnings per share is -$12.22

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$740.87 M
MRTX annual net profit is -$740.87 million

Annual Revenue

$12.44 M
MRTX annual revenue is $12.44 million

Annual Cost Of Goods Sold

$600.00 K
MRTX annual cost of goods sold is $600.00 thousand

Annual Operating Expenses

$771.42 M
MRTX annual total operating expenses is $771.42 million

Annual Interest Expense

-
MRTX annual interest expense value is unknown

Annual Income Tax

$508.00 K
MRTX annual income tax is $508.00 thousand

MRTX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.3%+6.7%+1.6%
3 y3 years-248.1%-83.6%-121.0%
5 y5 years-951.1%-489.4%-241.0%

MRTX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+27.3%at lowat high+25.1%+24.8%+2.1%
5 y5-year+248.1%at low+123.7%+25.1%+241.0%+2.1%
alltimeall time>+9999.0%at low-2194.0%+25.1%>+9999.0%+2.1%

Mirati Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2023
-
-$161.90 M(-8.5%)
-$725.88 M(-1.6%)
Jun 2023
-
-$176.91 M(-4.2%)
-$737.53 M(+0.1%)
Mar 2023
-
-$184.59 M(-8.8%)
-$737.07 M(-0.5%)
Dec 2022
-$740.87 M(+27.3%)
-$202.47 M(+16.7%)
-$740.87 M(+0.4%)
Sep 2022
-
-$173.56 M(-1.6%)
-$738.01 M(+14.5%)
Jun 2022
-
-$176.44 M(-6.3%)
-$644.50 M(+1.6%)
Mar 2022
-
-$188.39 M(-5.6%)
-$634.35 M(+9.1%)
Dec 2021
-$581.78 M(+62.5%)
-$199.62 M(+149.4%)
-$581.64 M(+20.3%)
Sep 2021
-
-$80.05 M(-51.9%)
-$483.67 M(-1.6%)
Jun 2021
-
-$166.28 M(+22.6%)
-$491.78 M(+20.9%)
Mar 2021
-
-$135.68 M(+33.5%)
-$406.78 M(+13.7%)
Dec 2020
-$357.94 M(+68.2%)
-$101.66 M(+15.3%)
-$357.75 M(+8.9%)
Sep 2020
-
-$88.16 M(+8.5%)
-$328.48 M(+11.5%)
Jun 2020
-
-$81.28 M(-6.2%)
-$294.49 M(+13.8%)
Mar 2020
-
-$86.66 M(+19.7%)
-$258.75 M(+21.6%)
Dec 2019
-$212.85 M(+116.3%)
-$72.38 M(+33.6%)
-$212.85 M(+26.2%)
Sep 2019
-
-$54.17 M(+18.9%)
-$168.71 M(+18.8%)
Jun 2019
-
-$45.54 M(+11.8%)
-$142.00 M(+14.4%)
Mar 2019
-
-$40.75 M(+44.3%)
-$124.17 M(+26.2%)
Dec 2018
-$98.42 M(+39.6%)
-$28.24 M(+2.8%)
-$98.42 M(+11.7%)
Sep 2018
-
-$27.47 M(-0.9%)
-$88.13 M(+14.4%)
Jun 2018
-
-$27.71 M(+84.8%)
-$77.01 M(+13.7%)
Mar 2018
-
-$15.00 M(-16.4%)
-$67.74 M(-3.9%)
Dec 2017
-$70.48 M(-15.2%)
-$17.95 M(+9.8%)
-$70.52 M(-2.5%)
Sep 2017
-
-$16.35 M(-11.3%)
-$72.34 M(-4.1%)
Jun 2017
-
-$18.44 M(+3.8%)
-$75.45 M(-4.5%)
Mar 2017
-
-$17.77 M(-10.1%)
-$79.03 M(-4.9%)
Dec 2016
-$83.14 M(+28.9%)
-$19.77 M(+1.6%)
-$83.14 M(+1.7%)
Sep 2016
-
-$19.45 M(-11.7%)
-$81.75 M(+0.9%)
Jun 2016
-
-$22.03 M(+0.6%)
-$81.03 M(+8.8%)
Mar 2016
-
-$21.89 M(+19.1%)
-$74.46 M(+15.4%)
Dec 2015
-$64.51 M(+47.7%)
-$18.38 M(-1.9%)
-$64.51 M(+14.1%)
Sep 2015
-
-$18.73 M(+21.2%)
-$56.52 M(+21.8%)
Jun 2015
-
-$15.46 M(+29.5%)
-$46.41 M(+10.6%)
Mar 2015
-
-$11.94 M(+14.8%)
-$41.97 M(-3.9%)
Dec 2014
-$43.68 M
-$10.39 M(+20.5%)
-$43.68 M(-1.9%)
Sep 2014
-
-$8.63 M(-21.7%)
-$44.53 M(-31.8%)
Jun 2014
-
-$11.01 M(-19.3%)
-$65.30 M(+4.8%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$13.65 M(+21.3%)
-$62.30 M(+17.8%)
Dec 2013
-$52.87 M(+160.6%)
-$11.25 M(-61.7%)
-$52.87 M(+10.3%)
Sep 2013
-
-$29.40 M(+266.9%)
-$47.93 M(+95.8%)
Jun 2013
-
-$8.01 M(+90.0%)
-$24.48 M(+15.8%)
Mar 2013
-
-$4.22 M(-33.1%)
-$21.15 M(+4.2%)
Dec 2012
-$20.29 M(+112.9%)
-$6.31 M(+6.1%)
-$20.29 M(+15.2%)
Sep 2012
-
-$5.95 M(+27.1%)
-$17.61 M(+20.4%)
Jun 2012
-
-$4.68 M(+39.4%)
-$14.63 M(+27.5%)
Mar 2012
-
-$3.36 M(-7.5%)
-$11.47 M(+17.9%)
Dec 2011
-$9.53 M(-35.0%)
-$3.63 M(+22.3%)
-$9.73 M(+15.2%)
Sep 2011
-
-$2.97 M(+95.2%)
-$8.44 M(-16.7%)
Jun 2011
-
-$1.52 M(-6.0%)
-$10.14 M(-14.0%)
Mar 2011
-
-$1.62 M(-31.0%)
-$11.80 M(-19.4%)
Dec 2010
-$14.65 M(-35.0%)
-$2.34 M(-49.8%)
-$14.64 M(-16.7%)
Sep 2010
-
-$4.67 M(+46.9%)
-$17.57 M(-2.3%)
Jun 2010
-
-$3.18 M(-28.6%)
-$17.97 M(-13.4%)
Mar 2010
-
-$4.45 M(-15.5%)
-$20.75 M(-1.8%)
Dec 2009
-$22.53 M(+207.4%)
-$5.27 M(+3.9%)
-$21.14 M(+159.8%)
Sep 2009
-
-$5.07 M(-14.9%)
-$8.14 M(+30.8%)
Jun 2009
-
-$5.96 M(+23.1%)
-$6.22 M(-17.1%)
Mar 2009
-
-$4.84 M(-162.6%)
-$7.51 M(-3.1%)
Dec 2008
-$7.33 M(-67.0%)
$7.73 M(-345.0%)
-$7.75 M(-65.7%)
Sep 2008
-
-$3.16 M(-56.4%)
-$22.59 M(-9.8%)
Jun 2008
-
-$7.24 M(+42.5%)
-$25.03 M(+6.0%)
Mar 2008
-
-$5.08 M(-28.5%)
-$23.62 M(+10.6%)
Dec 2007
-$22.24 M(+245.1%)
-$7.11 M(+27.0%)
-$21.36 M(+32.9%)
Sep 2007
-
-$5.60 M(-4.0%)
-$16.07 M(+107.0%)
Jun 2007
-
-$5.83 M(+106.7%)
-$7.76 M(+40.7%)
Mar 2007
-
-$2.82 M(+54.9%)
-$5.52 M(-12.3%)
Dec 2006
-$6.44 M(-51.0%)
-$1.82 M(-167.3%)
-$6.29 M(-27.6%)
Sep 2006
-
$2.71 M(-175.6%)
-$8.70 M(-41.1%)
Jun 2006
-
-$3.58 M(-0.4%)
-$14.75 M(+4.1%)
Mar 2006
-
-$3.60 M(-14.8%)
-$14.17 M(+9.8%)
Dec 2005
-$13.17 M(+43.9%)
-$4.22 M(+26.0%)
-$12.91 M(+48.6%)
Sep 2005
-
-$3.35 M(+11.6%)
-$8.69 M(+62.8%)
Jun 2005
-
-$3.00 M(+28.6%)
-$5.34 M(+128.6%)
Mar 2005
-
-$2.33 M
-$2.33 M
Dec 2004
-$9.15 M(+116.7%)
-
-
Dec 2003
-$4.22 M
-
-

FAQ

  • What is Mirati Therapeutics annual net profit?
  • What is the all time high annual net income for Mirati Therapeutics?
  • What is Mirati Therapeutics annual net income year-on-year change?
  • What is Mirati Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Mirati Therapeutics?
  • What is Mirati Therapeutics quarterly net income year-on-year change?
  • What is Mirati Therapeutics TTM net profit?
  • What is the all time high TTM net income for Mirati Therapeutics?
  • What is Mirati Therapeutics TTM net income year-on-year change?

What is Mirati Therapeutics annual net profit?

The current annual net income of MRTX is -$740.87 M

What is the all time high annual net income for Mirati Therapeutics?

Mirati Therapeutics all-time high annual net profit is -$4.22 M

What is Mirati Therapeutics annual net income year-on-year change?

Over the past year, MRTX annual net profit has changed by -$159.08 M (-27.34%)

What is Mirati Therapeutics quarterly net profit?

The current quarterly net income of MRTX is -$161.90 M

What is the all time high quarterly net income for Mirati Therapeutics?

Mirati Therapeutics all-time high quarterly net profit is $7.73 M

What is Mirati Therapeutics quarterly net income year-on-year change?

Over the past year, MRTX quarterly net profit has changed by +$11.66 M (+6.72%)

What is Mirati Therapeutics TTM net profit?

The current TTM net income of MRTX is -$725.88 M

What is the all time high TTM net income for Mirati Therapeutics?

Mirati Therapeutics all-time high TTM net profit is -$2.33 M

What is Mirati Therapeutics TTM net income year-on-year change?

Over the past year, MRTX TTM net profit has changed by +$12.13 M (+1.64%)